Article

SUNCT/SUNA and neurovascular compression: New cases and critical literature review

IRCCS Institute of Neurological Sciences of Bologna, Headache Centre, Department of Biomedical and Neuromotor Sciences, University of Bologna, Italy.
Cephalalgia (Impact Factor: 4.12). 06/2013; 33(16). DOI: 10.1177/0333102413494273
Source: PubMed

ABSTRACT Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) and short-lasting unilateral neuralgiform headache with cranial autonomic symptoms (SUNA) are primary headache syndromes. A growing body of literature has focused on brain magnetic resonance imaging (MRI) evidence of neurovascular compression in these syndromes.
The objective of this article is to assess whether SUNCT is a subset of SUNA or whether the two are separate syndromes and clarify the role of neurovascular compression.
We describe three new SUNCT cases with MRI findings of neurovascular compression and critically review published SUNCT/SUNA cases.
We identified 222 published SUNCT/SUNA cases. Our three patients with neurovascular compression added to the 34 cases previously described (16.9%). SUNCT and SUNA share the same clinical features and therapeutic options. At present, there is no available abortive treatment for attacks. Lamotrigine was effective in 64% of patients; topiramate and gabapentin in about one-third of cases. Of the 34 cases with neurovascular compression, seven responded to drug therapies, 16 patients underwent microvascular decompression of the trigeminal nerve (MVD) with effectiveness in 75%.
We suggest that SUNCT and SUNA should be considered clinical phenotypes of the same syndrome. Brain MRI should always be performed with a dedicated view to exclude neurovascular compression. The high percentage of remission after MVD supports the pathogenetic role of neurovascular compression.

Download full-text

Full-text

Available from: Daniela Grimaldi, Jun 21, 2015
0 Followers
 · 
232 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Trigeminal autonomic cephalalgias are primary headaches characterized by unilateral pain and cranial autonomic symptoms. However, associated autonomic symptoms have also been reported in other headaches and facial pains, e.g. trigeminal neuralgia, with the clinical differentiation proving a complex task. A 54-year-old man presented with right-sided, sharp, intense facial pain in the distribution area of the trigeminal nerve. Pain duration was from seconds to a few minutes, and trigger factors included ipsilateral touching of the skin and hair. Over the next ten years, symptoms progressed and changed presentation, also displaying as right-sided, severe, orbital pain, lasting 60 to 90 minutes, with conjunctival injection and rhinorrhea. Neurological examination was normal. Numerous medications were tried with limited or no effect. In 2010, magnetic resonance imaging revealed a right-sided deviation of the basilar artery at the level of pons, creating neurovascular contact with the trigeminal nerve. Microvascular decompression was performed, and symptoms resolved within days. Differentiating between trigeminal autonomic cephalalgias and trigeminal neuralgia with autonomic symptoms can be challenging. The distinct change and evolution over time in the clinical presentation of the patient's head pain suggests a temporal plasticity of the pain in head and facial syndromes, irrespective of underlying pathoanatomic features.
    The Journal of Headache and Pain 12/2015; 16(1). DOI:10.1186/s10194-015-0497-5 · 3.28 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: To report the first ever case of primary short-lasting unilateral neuralgiform headache attacks (SUNCT) syndrome completely responsive to clomiphene citrate. Case report. SUNCT is a primary headache disorder marked by frequent attacks of one-sided headache with cranial autonomic associated symptoms. When SUNCT is deemed medicinally treatment refractory, it can cause tremendous patient-related disability. Surgical treatment options are available including hypothalamic deep brain stimulation, occipital nerve stimulator placement or arterial decompression surgery, but these procedures carry significant morbidity. A patient presented with a 10 month complaint of multiple, daily short-lasting, right-sided headaches each lasting from 60 to 120 seconds in duration and occurring from 100 to 200 times per day. The head pain was associated with ipsilateral eyelid ptosis and conjunctival injection. The patient was diagnosed with SUNCT but was unresponsive to multiple recognized medicinal treatments. He had complete alleviation of his attacks with clomiphene citrate, a synthetic, non-steroidal, ovulatory stimulant that directly binds to hypothalamic estrogen receptors. The clomiphene was tolerated without any adverse events. A putative mechanism of action for clomiphene in the prevention of SUNCT will be presented. Clomiphene citrate is a unique treatment for SUNCT and appears to be very safe and effective.
    Cephalalgia 03/2014; 34(12). DOI:10.1177/0333102414527647 · 4.12 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Clusterkopfschmerz, paroxysmale Hemikranie und ,,short-lasting unilateral neuralgiform headache attacks with conjuntival injection and tearing“ (SUNCT-Syndrom) werden unter den trigeminoautonomen Kopfschmerzerkrankungen (,,trigemino autonomic cephalalgia; TAC) zusammengefasst. Die neue vorgeschlagene internationale Klassifikation der Kopfschmerzerkrankungen (ICDH-3 beta) zählt nun auch die Hemicrania continua zu dieser Gruppe, außerdem wurden die Diagnosekriterien der anderen TACs modifiziert. TACs sind durch ständige oder in Attacken auftretende Kopfschmerzen mit zusätzlichen kranial autonomen Begleitsymptomen charakterisiert. Sie unterscheiden sich in ihrer Attackendauer und müssen wegen unterschiedlicher pharmakologischer Therapiestrategien voneinander abgegrenzt werden.
    Der Nervenarzt 12/2013; 84(12). DOI:10.1007/s00115-012-3624-4 · 0.86 Impact Factor